API under pending BLA
QUESTION: Under 21 CFR section 201.122 (c), import of an API (drug substance) for further manufacturing/use in a drug (commercial/human use) is permissible under a pending or near approval of an FDA application (BLA in this instance) so long as affirmation that the API will not be exported and that the products manufactured with the […]